Catalyst Pharmaceuticals Inc (CPRX)

Exchange
NASDAQ
Symbol
CPRX
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, neuromuscular, and chronic neurological diseases in the United States. The company is headquartered in Coral Gables, Florida.
Country
USA

Stock price

At close: December 20, 2024

  • Open
    21.27
  • High
    21.41
  • Low
    21.01
  • Close
    21.27
  • Volume
    1,753,340

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
12.87
Receivables turnover
7.44
Payables turnover
13.60
Working capital turnover
2.78
Days of inventory on hand (DOH)
28.37
Days of sales outstanding (DSO)
49.05
Number of days of payables
26.83
Fixed asset turnover
333.23
Total asset turnover
0.85
 Liquidity ratios
Current ratio
2.88
Quick ratio
2.51
Cash ratio
1.81
Cash conversion cycle
50.59
 Solvency ratios
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
1.21
Interest coverage
—
 Profitability ratios
Gross profit margin
49.46%
Operating profit margin
21.80%
Pretax margin
23.73%
Net profit margin
17.93%
Operating return on assets (Operating ROA)
18.47%
Return on assets (ROA)
15.19%
Return on total capital
22.38%
Return on equity (ROE)
18.41%